Vol. I No. 1Published by Northbank Media Independent · No advertising network
The mortality gap · Conditions

Skin cancer in men: the mortality gap and where it comes from

The difference in outcome is not mainly biological. It is behavioural, and behaviour is the part that can be changed.

Hard midday sun across a back
Hard midday sun across a back. The trunk is the commonest male melanoma site and the hardest to self-examine.
The short answer

Men in the UK have worse melanoma outcomes than women. Several contributing factors are consistently identified: men are less likely to use sun protection, more likely to have high occupational and recreational ultraviolet exposure, less likely to check their own skin or have anyone else check it, and more likely to present at a later stage. Site distribution differs too, with the back and trunk more common in men and more difficult to self-examine. The clinical response is unglamorous: reduce ultraviolet exposure, know the changes that warrant assessment, and use the NHS urgent referral pathway when they occur.

This is the one article on this site where the stakes are not cosmetic. Melanoma is the skin cancer that kills, and UK data has consistently shown worse outcomes in men. The reasons are largely behavioural, which means they are among the few things in this field that can genuinely be changed by knowing about them.

1. The three that matter

Basal cell carcinoma. The most common skin cancer. Slow growing, locally destructive, almost never spreads. Typically a pearly or translucent papule, sometimes with visible vessels, that may bleed, crust and fail to heal. Common on the head, neck and ears, which in men are frequently the most exposed sites.

Squamous cell carcinoma. Arises from keratinocytes, usually on chronically sun exposed sites. Can be a scaly, tender, rapidly growing lump. Has the capacity to spread, particularly at certain sites and in immunosuppressed people, so it is treated more urgently than basal cell carcinoma. Actinic keratoses, rough scaly patches on sun damaged skin, are the precursor lesions.

Melanoma. Arises from melanocytes. Far less common than the other two and responsible for the majority of skin cancer deaths. It can arise in an existing mole or as a new lesion, and outcome depends heavily on the depth at which it is removed, which is why early presentation matters more here than almost anywhere else in dermatology.

2. Where the male disadvantage comes from

  • Later presentation. Men are consistently reported as presenting with thicker melanomas, and thickness at diagnosis is the strongest determinant of outcome.
  • Site. The back and trunk are more common male sites and are the hardest areas for a person to examine.
  • Less skin checking. Men are less likely to examine their own skin and less likely to have a partner who does it for them.
  • Less sun protection. Sunscreen use is consistently lower among men, as discussed in sunscreen and men.
  • Occupational exposure. Outdoor trades are heavily male, and cumulative occupational ultraviolet exposure is a recognised risk factor.
  • Scalp exposure. Male pattern hair loss exposes a site that is otherwise protected, and the scalp is easy to neglect and hard to see.
Thickness at diagnosis decides the outcome. Presentation decides the thickness.

3. What to look for

The widely taught ABCDE prompts remain useful for pigmented lesions: Asymmetry, Border irregularity, Colour variation, Diameter that is increasing, and Evolution, meaning any change over time.

Two additional principles matter more in practice. The ugly duckling sign: a lesion that looks different from the person's other moles is more significant than one that meets a checklist. And change of any kind: a mole that has started to itch, bleed, crust, change shape or change colour is a reason to be seen, regardless of whether it satisfies any acronym.

Non-pigmented lesions need a different prompt. Any sore, lump or scaly patch that has not healed within a month, particularly on the head, neck, ears, scalp, forearms or hands, warrants assessment.

4. The UK pathway

NICE guideline NG12 sets out the referral thresholds for suspected cancer, including the two week wait pathway for suspected melanoma and for suspected squamous cell carcinoma. A GP is the entry point. In practice, taking a photograph with a ruler or a coin for scale, and being able to say how long the change has been happening, makes the consultation considerably more useful.

The NHS does not offer population wide skin screening, because the evidence has not supported it. Private mole mapping services exist; they can be useful for people with very large numbers of moles or a strong family history, and they are not a substitute for getting a changing lesion looked at promptly.

5. Sunbeds

Artificial ultraviolet tanning is classified as carcinogenic to humans, and use before the age of 35 is associated with a substantially increased melanoma risk. In England and Wales it is illegal for under eighteens to use commercial sunbeds. There is no protective or preparatory benefit that survives scrutiny: the idea of building a base tan is a misunderstanding of what a tan is, which is evidence of ultraviolet induced DNA damage.

6. Who is at higher risk

  • Fair skin that burns easily, red or fair hair, freckling, light eyes.
  • A large number of moles, or atypical moles.
  • A personal or family history of melanoma or other skin cancer.
  • Significant cumulative exposure, particularly with episodes of severe sunburn.
  • Immunosuppression, including after organ transplantation, where squamous cell carcinoma risk is markedly increased and surveillance is routine.
  • Outdoor occupations, where exposure is chronic rather than episodic.

Richly pigmented skin carries lower risk but not zero risk, and melanoma at acral sites, the soles, palms and nail units, is proportionally more significant. Late diagnosis is a recognised problem in these groups, as noted in male skin of colour.

7. What to actually do

Three things, in order of impact. Reduce ultraviolet exposure, using shade and clothing first and sunscreen as the third line rather than the only line. Check your skin every few months, including the back with a mirror or a partner's help, and the scalp if hair is thinning. And go early when something changes, because the entire outcome distribution in melanoma is a function of how thick the lesion is when it is removed.

8. How to actually check, in five minutes

A skin check is only useful if it is repeatable, and most men either never do one or do it once haphazardly. A workable routine takes about five minutes and should be done every couple of months, in good light, after a shower.

Work top to bottom. Scalp, using a comb to part the hair or a second person, and paying attention to any area of thinning. Ears, including the upper rim and behind them. Face, neck and the front of the chest. Arms, including the backs of the hands, the nail beds and between the fingers. Trunk, front and back, using a mirror or a partner, since the back is the commonest male melanoma site and the least visible. Legs, feet, the soles and between the toes.

Photograph anything you are unsure about, with a coin or a ruler for scale, and compare in six weeks. A lesion that has changed in that period is a reason to make an appointment, not to take another photograph. The referral thresholds are set out in NICE guideline NG12.

No commercial links on this page

This article contains no affiliate links, no sponsored placements and no links to any commercial product, brand, retailer or clinic. Nobody paid for it, nobody previewed it and nobody outside the editorial desk saw it before publication. Our editorial standards set out the three archive articles that are the single disclosed exception on this site, none of which is this one.

Nothing here is medical advice. For your own skin, speak to a pharmacist, a GP or a dermatologist.

Sources

Institution level references. We link to bodies that publish their methods, not to retailers or clinic marketing. External links open on those bodies' own sites.

  1. NHSPatient information on melanoma and non-melanoma skin cancer, including what changes to look for and how referral works.https://www.nhs.uk/conditions/melanoma-skin-cancer/
  2. NICE guideline NG12Suspected cancer: recognition and referral. Sets out the UK thresholds for urgent referral of suspected skin cancer.https://www.nice.org.uk/guidance/ng12
  3. Cancer Research UKStatistics and professional information on melanoma incidence, mortality and risk factors in the UK.https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/melanoma-skin-cancer
  4. World Health OrganizationFact sheet on ultraviolet radiation, including the classification of tanning devices and health effects of exposure.https://www.who.int/news-room/fact-sheets/detail/ultraviolet-radiation

Frequently asked questions

Why do men do worse with melanoma?

Contributing factors consistently identified include later presentation, tumours more often on the back where they are hard to see, lower rates of skin checking, lower sunscreen use and higher occupational exposure.

What should I look for on my own skin?

Asymmetry, irregular borders, varied colour, increasing size and any change over time in a pigmented lesion. Also any mole that looks different from your others, and any sore or scaly patch that has not healed within a month.

Does the NHS screen for skin cancer?

There is no population screening programme, because the evidence has not supported one. The system relies on people presenting with changes and on GPs using the urgent referral pathway.

Are sunbeds safer than the sun?

No. Artificial ultraviolet tanning is classified as carcinogenic to humans, and use before the age of 35 is associated with substantially increased melanoma risk. There is no safe preparatory tan.

Can people with darker skin get skin cancer?

Yes, at lower rates but with a greater tendency to late diagnosis. Acral sites such as the soles, palms and nail units carry particular importance and are easily missed.

The weekly briefing

One email a week on male skin: what has been published, what has changed in UK guidance, and what it means in practice.

One email a week. One lead piece, what has been published, and at most one labelled placement. Never sold, never shared.